Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will ...

Quest Diagnostics has introduced a new pharmacogenomic (PGx) laboratory testing service designed to assist healthcare ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest reports a sharp rise in fentanyl use in U.S. workplace drug tests, raising concerns about safety, addiction and ...

SECAUCUS, N.J., July 15, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the ...

Company to be able to perform approximately 30,000 tests a week by the end of July, supplementing public health response Physicians can order the novel Quest Diagnostics lab test beginning today and ...

A new report from Quest Diagnostics, a diagnostic testing and health information services provider, revealed that the ...

The percentage of employees in the general U.S. workforce who had tested positive for fentanyl in random drug tests was far ...

The positivity rate for urine tests indicating the presence of the deadly synthetic opioid was 0.55% in 2024, increasing ...

Quest Diagnostics plans to acquire Canada-based community laboratory provider LifeLabs in a deal worth nearly $1 billion. Under the agreement announced July 3, the Secaucus-headquartered testing ...